• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Avaya Holdings Shares Are Trading Lower By 62%? Here Are 62 Stocks Moving In Friday's Mid-Day Session

    12/16/22 1:47:00 PM ET
    $ADAG
    $ADBE
    $AGFY
    $AGYS
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Computer Software: Prepackaged Software
    Technology
    Get the next $ADAG alert in real time by email

    Gainers

    • Allarity Therapeutics, Inc. (NASDAQ:ALLR) gained 240% to $0.90. Allarity Therapeutics, last month, posted a Q3 loss of $0.68 per share.
    • Maxar Technologies Inc. (NYSE:MAXR) shares jumped 120.2% to $50.86 after the company announced it will be acquired by Advent International for $6.4 billion.
    • Trean Insurance Group, Inc. (NASDAQ:TIG) gained 92.2% to $6.00 after the company announced a definitive agreement to be acquired by Altaris Capital Partners for $6.15 per share in cash.
    • Dermata Therapeutics, Inc. (NASDAQ:DRMA) jumped 82% to $0.3549. Dermata Therapeutics recently announced topline results from its DMT310 Phase 2 trial, which did not meet primary endpoints.
    • BeyondSpring Inc. (NASDAQ:BYSI) gained 39% to $2.1286. BeyondSpring recently presented data with plinabulin for the prevention of docetaxel-induced neutropenia in patients with non-small cell lung cancer and breast cancer at three medical conferences.
    • Minim, Inc. (NASDAQ:MINM) shares gained 32.5% to $0.2315 after gaining over 10% on Thursday. Minim, last month, reported worse-than-expected results.
    • authID Inc. (NASDAQ:AUID) gained 24.8% to $0.8995.
    • Ambrx Biopharma Inc. (NYSE:AMAM) jumped 23.2% to $2.7775.
    • Exact Sciences Corporation (NASDAQ:EXAS) shares gained 23.1% to $54.90 after competitor Guardant Health reported results from a study of its colorectal cancer detection blood test.
    • Future FinTech Group Inc. (NASDAQ:FTFT) jumped 21.7% to $0.4410
    • Nocera, Inc. (NASDAQ:NCRA) gained 20.8% to $1.51.
    • Adagene Inc. (NASDAQ:ADAG) jumped 19.8% to $1.5818. Adagene announced clinical trial collaboration to evaluate anti-CTLA-4 SAFEbody ADG126 in combination with Roche's standard-of-care for first-line advanced liver cancer.
    • COMSovereign Holding Corp. (NASDAQ:COMS) rose 18.8% to $0.0870.
    • Recruiter.com Group, Inc. (NASDAQ:RCRT) jumped 17.4% to $0.44.
    • Applied UV, Inc. (NASDAQ:AUVI) gained 17% to $1.12 after the company announced it signed a strategic manufacturing and related services agreement with Canon Virginia.
    • Lanvin Group (NASDAQ:LANV) shares gained 17% to $8.93 after dropping over 22% on Thursday.
    • Crown ElectroKinetics Corp. (NASDAQ:CRKN) climbed 16.8% to $0.2146 after jumping around 20% on Thursday.
    • Gelesis Holdings, Inc. (NYSE:GLS) rose 16.5% to $0.2601.
    • United Insurance Holdings Corp. (NASDAQ:UIHC) gained 15.5% to $0.5664.
    • TAL Education Group (NYSE:TAL) jumped 15.5% to $7.53.
    • Bit Brother Limited (NASDAQ:BTB) rose 14.7% to $7.26 after gaining 24% on Thursday. Bit Brother recently announced a 1-for-15 reverse share split.
    • Phio Pharmaceuticals Corp. (NASDAQ:PHIO) gained 13.8% to $0.41. Phio Pharmaceuticals, last month, posted a Q3 loss of $0.26 per share.
    • Apollo Medical Holdings, Inc. (NASDAQ:AMEH) surged 12.3% to $30.51. Apollo Medical announced a $50 million share repurchase program.
    • Agilysys, Inc. (NASDAQ:AGYS) jumped 11.6% to $78.70. BTIG upgraded Agilysys from Neutral to Buy.
    • Scholastic Corporation (NASDAQ:SCHL) gained 10.6% to $38.74 after the company posted Q2 results and raised buyback program to $75 million.
    • New Oriental Education & Technology Group Inc. (NYSE:EDU) surged 10.6% to $36.88.
    • Arteris, Inc. (NASDAQ:AIP) gained 10.4% to $3.81.
    • Sharps Technology, Inc. (NASDAQ:STSS) jumped 10% to $1.32.
    • Planet Labs PBC (NYSE:PL) gained 9.4% to $5.39. Planet Labs recently reported better-than-expected financial results and issued strong guidance.
    • EUDA Health Holdings Limited (NASDAQ:EUDA) rose 9.1% to $1.80 after gaining around 18% on Thursday.
    • Adobe Inc. (NASDAQ:ADBE) rose 6% to $348.48 after the company reported better-than-expected earnings for its fourth quarter. Adobe said it sees full-year revenue in a range of $19.1 billion to $19.3 billion versus estimates of $19.37 billion. The company expects full-year adjusted earnings to be between $15.15 and $15.45 per share versus estimates of $15.25 per share.


    Losers

    • Synaptogenix, Inc. (NASDAQ:SNPX) shares dipped 72.6% to $1.2950 after the company announced Phase 2 clinical trial of Bryostatin-1 for Advanced Alzheimer's disease. The company said endpoint was not met with statistical significance.
    • Avaya Holdings Corp. (NYSE:AVYA) shares fell 62% to $0.1999 following a Wall Street Journal report suggesting the company is nearing a chapter 11 bankruptcy filing.
    • Starry Group Holdings, Inc. (NYSE:STRY) dropped 61% to $0.0150. Starry said NYSE has commenced delisting proceedings.
    • BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV) fell 54% to $4.04 after the company priced its 1.6 million unit offering at $5.00 per unit.
    • Cosmos Holdings Inc. (NASDAQ:COSM) fell 52.9% to $3.89 following effect of 1:25 reverse stock split.
    • Agrify Corporation (NASDAQ:AGFY) shares fell 51% to $0.3999 after the company announced pricing of a public offering.
    • Scopus BioPharma Inc. (NASDAQ:SCPS) fell 43% to $0.1930 after climbing around 45% on Thursday.
    • NantHealth, Inc. (NASDAQ:NH) dropped 36% to $1.83.
    • Guardant Health, Inc. (NASDAQ:GH) dropped 30.9% to $28.50 after the company announced results from its ECLIPSE study evaluating the performance of its blood test for detecting colorectal cancer.
    • IMV Inc. (NASDAQ:IMV) fell 27.4% to $2.64 after the company announced a $9 million registered direct offering price at-the-market under Nasdaq rules.
    • Faraday Future Intelligent Electric Inc. (NASDAQ:FFIE) fell 26.8% to $0.3514. Faraday Future announced plans to start production of FF 91 Futurist in March 2023 and outlined financing progress and completion of product upgrades.
    • 180 Life Sciences Corp. (NASDAQ:ATNF) fell 22.4% to $0.2099. 180 Life Sciences announced a 1-for-20 reverse stock split as part of Nasdaq compliance plan.
    • MicroAlgo Inc. (NASDAQ:MLGO) fell 21% to $1.77.
    • Camber Energy, Inc. (NYSE:CEI) fell 20.3% to $0.0625. Camber Energy announced one-for-fifty reverse stock split.
    • Axcella Health Inc. (NASDAQ:AXLA) dropped 20.2% to $0.3502. SVB Leerink downgraded Axcella Health from Outperform to Market Perform and lowered the price target from $6 to $2.
    • Core Scientific, Inc. (NASDAQ:CORZ) fell 19.6% to $0.3457.
    • Cemtrex, Inc. (NASDAQ:CETX) dropped 18.2% to $0.1390.
    • China Jo-Jo Drugstores, Inc. (NASDAQ:CJJD) fell 17.6% to $4.49.
    • Meiwu Technology Company Limited (NASDAQ:WNW) declined 17.4% to $1.85.
    • Vallon Pharmaceuticals, Inc. (NASDAQ:VLON) fell 17% to $0.3056.
    • MorphoSys AG (NASDAQ:MOR) shares fell 12.8% to $3.48. MorphoSys subsidiary Constellation Pharmaceuticals recently entered into a global licensing agreement with Novartis to research, develop and commercialize its pre-clinical inhibitors of a novel cancer target.
    • ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) dipped 12.6% to $7.39.
    • MorphoSys AG (NASDAQ:MOR) fell 12.5% to $3.49.
    • TG Therapeutics, Inc. (NASDAQ:TGTX) declined 11.8% to $7.59.
    • Icosavax, Inc. (NASDAQ:ICVX) fell 11.8% to $8.99.
    • SharpLink Gaming Ltd. (NASDAQ:SBET) dropped 11% to $0.3915.
    • Novavax, Inc. (NASDAQ:NVAX) fell 10.6% to $10.13. Novavax said it has priced its underwritten public offering to sell 6.5 million shares of its common stock at $10 per share.
    • Focus Universal Inc. (NASDAQ:FCUV) fell 10.5% to $7.18.
    • Sea Limited (NYSE:SE) fell 9.4% to $55.27.
    • Krispy Kreme, Inc. (NASDAQ:DNUT) dropped 8.4% to $12.19. Krispy Kreme reiterated its FY22 financial guidance.
    • Coinbase Global, Inc. (NASDAQ:COIN) dropped 6.2% to $35.68.

    Also check this out 5 Most Overvalued Stocks In The Industrials Sector: Aerojet Rocketdyne, Triton International And More.

    Get the next $ADAG alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADAG
    $ADBE
    $AGFY
    $AGYS

    CompanyDatePrice TargetRatingAnalyst
    Sharplink Inc.
    $SBET
    4/7/2026$10.00Buy
    H.C. Wainwright
    Krispy Kreme Inc.
    $DNUT
    3/26/2026$6.00Equal Weight → Overweight
    CapitalOne
    Adobe Inc.
    $ADBE
    3/26/2026Mkt Perform
    William Blair
    Adobe Inc.
    $ADBE
    3/16/2026Buy → Hold
    Argus
    Adobe Inc.
    $ADBE
    3/13/2026$275.00Overweight → Equal Weight
    Barclays
    Adobe Inc.
    $ADBE
    3/13/2026$375.00 → $285.00Market Perform
    BMO Capital Markets
    Scholastic Corporation
    $SCHL
    3/9/2026Buy → Neutral
    B. Riley Securities
    Core Scientific Inc.
    $CORZ
    3/3/2026$23.00Hold → Buy
    Needham
    More analyst ratings

    $ADAG
    $ADBE
    $AGFY
    $AGYS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SVP, Regulatory Affairs Bedoya-Toro Munera Maria E bought $1,270 worth of shares (1,000 units at $1.27), increasing direct ownership by 8,333% to 1,012 units (SEC Form 4)

    4 - Dermata Therapeutics, Inc. (0001853816) (Issuer)

    3/17/26 5:44:21 PM ET
    $DRMA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Weiss Eric Stanton bought $101,700 worth of shares (7,000 units at $14.53), increasing direct ownership by 3% to 252,262 units (SEC Form 4)

    4 - Core Scientific, Inc./tx (0001839341) (Issuer)

    3/10/26 4:08:53 PM ET
    $CORZ
    Finance: Consumer Services
    Finance

    Chief Executive Officer Siokas Grigorios bought $145,000 worth of shares (388,532 units at $0.37), increasing direct ownership by 5% to 8,861,914 units (SEC Form 4)

    4 - Cosmos Health Inc. (0001474167) (Issuer)

    2/13/26 10:05:37 AM ET
    $COSM
    Other Pharmaceuticals
    Health Care

    $ADAG
    $ADBE
    $AGFY
    $AGYS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    H.C. Wainwright initiated coverage on SharpLink with a new price target

    H.C. Wainwright initiated coverage of SharpLink with a rating of Buy and set a new price target of $10.00

    4/7/26 8:49:46 AM ET
    $SBET
    Computer Software: Prepackaged Software
    Technology

    Krispy Kreme upgraded by CapitalOne with a new price target

    CapitalOne upgraded Krispy Kreme from Equal Weight to Overweight and set a new price target of $6.00

    3/26/26 8:53:37 AM ET
    $DNUT
    Food Chains
    Consumer Staples

    William Blair resumed coverage on Adobe

    William Blair resumed coverage of Adobe with a rating of Mkt Perform

    3/26/26 8:44:26 AM ET
    $ADBE
    Computer Software: Prepackaged Software
    Technology

    $ADAG
    $ADBE
    $AGFY
    $AGYS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Johnson Ashley F.

    4 - Planet Labs PBC (0001836833) (Issuer)

    4/6/26 6:01:44 PM ET
    $PL
    Radio And Television Broadcasting And Communications Equipment
    Technology

    SEC Form 4 filed by Hawkins Nicholas B.

    4 - Arteris, Inc. (0001667011) (Issuer)

    4/6/26 6:01:03 PM ET
    $AIP
    Semiconductors
    Technology

    SEC Form 4 filed by Moll Laurent R

    4 - Arteris, Inc. (0001667011) (Issuer)

    4/6/26 6:00:37 PM ET
    $AIP
    Semiconductors
    Technology

    $ADAG
    $ADBE
    $AGFY
    $AGYS
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for BRIUMVI issued to TG THERAPEUTICS, INC

    Submission status for TG THERAPEUTICS, INC's drug BRIUMVI (SUPPL-11) with active ingredient UBLITUXIMAB-XIIY has changed to 'Approval' on 10/30/2024. Application Category: BLA, Application Number: 761238, Application Classification:

    10/31/24 4:38:40 AM ET
    $TGTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    August 30, 2024 - La FDA autoriza la vacuna contra el COVID-19 de Novavax actualizada para brindar una mejor protección contra las variantes que circulan actualmente.

    For Immediate Release: August 30, 2024 English Hoy, la Administración de Alimentos y Medicamentos de los Estados Unidos (FDA, por sus siglas en inglés) otorgó una autorización de uso de emergencia (EUA, por sus siglas en inglés) para una versión actualizada de la vacuna contra el COVID-19 de Novavax que ataca más de cerca a las variantes que circulan actualmente para brindar una mejor protección contra las cons

    9/3/24 2:26:49 PM ET
    $NVAX
    $PFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    August 30, 2024 - FDA Authorizes Updated Novavax COVID-19 Vaccine to Better Protect Against Currently Circulating Variants

    For Immediate Release: August 30, 2024 Today, the U.S. Food and Drug Administration granted emergency use authorization (EUA) for an updated version of the Novavax COVID-19 vaccine that more closely targets currently circulating variants to provide better protection against serious consequences of COVID-19, including hospitalization and death. The updated vaccine is authorized for use in individuals 12 years of

    8/30/24 2:26:48 PM ET
    $NVAX
    $PFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    $ADAG
    $ADBE
    $AGFY
    $AGYS
    SEC Filings

    View All

    SEC Form 144 filed by Arteris Inc.

    144 - Arteris, Inc. (0001667011) (Subject)

    4/6/26 4:28:43 PM ET
    $AIP
    Semiconductors
    Technology

    Krispy Kreme Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - Krispy Kreme, Inc. (0001857154) (Filer)

    4/6/26 4:27:16 PM ET
    $DNUT
    Food Chains
    Consumer Staples

    Amendment: Krispy Kreme Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K/A - Krispy Kreme, Inc. (0001857154) (Filer)

    4/6/26 4:21:23 PM ET
    $DNUT
    Food Chains
    Consumer Staples

    $ADAG
    $ADBE
    $AGFY
    $AGYS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    100 Little Free Libraries Launch Nationwide featuring Dog Man Creator Dav Pilkey's Beloved Characters to Bring Books to Kids in Book Deserts

    ST. PAUL, Minn. and NEW YORK, April 7, 2026 /PRNewswire/ -- Little Free Library nonprofit organization whose mission is to expand book access is teaming up with Dog Man and Captain Underpants creator Dav Pilkey and Scholastic to spark book joy and expand access to reading across the United States. The 100 custom-designed Little Free Libraries featuring Dav Pilkey's beloved characters will be installed in schools, public libraries, and communities in book deserts, bringing books directly to children and families who need them most. The initiative, which launches today on the much-anticipated April 7th publication of Pilkey's Captain Underpants: The First Epic Manga and to celebrate National S

    4/7/26 10:24:00 AM ET
    $SCHL
    Books
    Consumer Discretionary

    Planet Successfully Runs AI in Space

    Using NVIDIA Jetson, Planet achieves AI-powered object detection on its Pelican satellite Following the announcement of a strategic initiative with NVIDIA, Planet Labs PBC (NYSE:PL) announced a landmark technical achievement: the successful deployment and execution of AI-driven object detection directly onboard its Pelican-4 satellite, paving the way toward on-orbit compute for rapid insights, a capability Planet calls Planetary Intelligence. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260407165913/en/Imagery captured by Pelican-4 on March 25, 2026 over Alice Springs, Australia, demonstrating the first successful deployment

    4/7/26 9:04:00 AM ET
    $PL
    Radio And Television Broadcasting And Communications Equipment
    Technology

    CEMTREX SUBSIDIARY, INVOCON, SELECTED FOR U.S. NAVY SBIR PHASE I CONTRACT IN NAVAL MINE WARFARE

    Hauppauge, NY, April 07, 2026 (GLOBE NEWSWIRE) -- – Cemtrex, Inc. (NASDAQ:CETX, CETXP)) today announced that its subsidiary Invocon, Inc. has been selected as an apparently successful offeror for a Phase I Small Business Innovation Research (SBIR) contract with the Naval Sea Systems Command (NAVSEA). The award, under topic N254-P02: NAVSEA Open Topic for Modular Mine Warfare Components, recognizes Invocon's technical capabilities in advanced defense electronics and power systems engineering. SBIR Phase I contracts are competitively awarded by the U.S. Department of Defense to small businesses demonstrating innovative solutions to defined military requirements. Invocon was among a limited

    4/7/26 8:45:00 AM ET
    $CETX
    Electrical Products
    Technology

    $ADAG
    $ADBE
    $AGFY
    $AGYS
    Financials

    Live finance-specific insights

    View All

    Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 4.803 Million Tokens, and Total Crypto and Total Cash Holdings of $11.4 Billion

    Bitmine has been approved for uplisting to the New York Stock Exchange ("NYSE") from the NYSE American effective at the opening of trading on April 9, 2026Bitmine has 3,334,637 staked ETH, representing $7.1 billion at $2,123 per ETHMAVAN (Made in America VAlidator Network) is the premier Ethereum staking destination for BMNR and institutional investors, with a focus on security, performance, and resilienceBitmine now owns 3.98% of the ETH token supply, over 79% of the way to the 'Alchemy of 5%' in just 9 monthsBitmine owns $92 million of ORBS, now one of the only publicly listed equities in the world to give investors direct exposure to OpenAIBitmine Crypto + Total Cash Holdings + "Moonshots

    4/6/26 8:30:00 AM ET
    $BMNR
    $COIN
    $MSTR
    Finance: Consumer Services
    Finance
    Computer Software: Prepackaged Software
    Technology

    authID Reports Financial and Operating Results for the Fourth Quarter 2025

    DENVER, March 31, 2026 (GLOBE NEWSWIRE) -- authID® (NASDAQ:AUID) ("authID" or the "Company"), a leading provider of biometric identity verification and authentication solutions, today reported financial and operating results for the Fourth Quarter and Fiscal Year ended December 31, 2025. Fourth Quarter 2025 vs. Fourth Quarter 2024 Financial Summary Total revenue for the quarter was $0.4 million, compared to $0.2 million a year ago.Operating expenses were $4.5 million, compared to $4.9 million a year ago.Net loss was $4.0 million, or $0.28 per share, compared to a loss of $4.6 million, or $0.42 per share a year ago.Adjusted EBITDA Loss of $3.0 million (non-GAAP measure as defined below),

    3/31/26 4:05:00 PM ET
    $AUID
    Computer Software: Prepackaged Software
    Technology

    Allarity Therapeutics Reports Full Year 2025 Financial Results and Corporate Progress

         Strengthened financial position through disciplined cost management, with a year-end 2025 cash position of $14.7 million and runway into mid-2028Received FDA Fast Track designation for stenoparib, enabling accelerated development in advanced ovarian cancerDurable clinical benefit observed in ongoing stenoparib ovarian cancer study, including patients treated for nearly 30 months, with new Phase 2 protocol implementedExpansion of stenoparib development beyond ovarian cancer with the launch of a VA-funded Phase 2 combination study in recurrent small cell lung cancer TARPON SPRINGS, Fla., March 31, 2026 – Allarity Therapeutics, Inc. ("Allarity" or the "Company") (NASDAQ:ALLR), a Phase 2

    3/31/26 8:00:00 AM ET
    $ALLR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADAG
    $ADBE
    $AGFY
    $AGYS
    Leadership Updates

    Live Leadership Updates

    View All

    Novavax Appoints Dr. Robert Walker as Executive Vice President and Head of Research & Development

    Robert Walker, MD, brings more than 30 years in drug and vaccine development and, most recently, served as Novavax's Chief Medical OfficerDr. Walker will continue advancing Novavax's R&D efforts with a focus on data generation to facilitate partnering discussions, Matrix adjuvant innovation and advancement of the Company pipeline  GAITHERSBURG, Md., March 30, 2026 /PRNewswire/ -- Novavax, Inc. (NASDAQ:NVAX) today announced the appointment of Dr. Robert Walker, MD, as Executive Vice President and Head of Research & Development (R&D). Dr. Walker now reports to John C. Jacobs, President and Chief Executive Officer of Novavax.A specialist in internal medicine and pulmonary and critical care medi

    3/30/26 8:00:00 AM ET
    $NVAX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Cosmos Health Provides Update; Evaluates Options to Address Valuation Disconnect; Will Issue Updated Guidance Following FY 2025 Results; Record Growth Continues as Significant U.S. Expansion Underway, with Additional $12M+ in High-Margin Revenue Projected; Important R&D Updates Expected Following Finalization of Certain Anticipated Transactions

    Continues to deliver record revenue and improving operating metricsSignificant expansion in the United States underway, with NOOR and other Sky Premium Life products expected to drive strong profitability supported by gross margins of approximately 75%NOOR Collagen alone is projected to generate more than $12 million in annualized revenue Strong growth expected ahead, driven by organic progress and M&A pipeline including a recent LOI to acquire an $11.5 million pharmacy distribution network Holds valuable non-core strategic real estate and digital assets with an estimated fair market value exceeding $18 million, providing meaningful balance sheet flexibilityEvaluating potential monetization

    3/19/26 12:45:00 PM ET
    $COSM
    Other Pharmaceuticals
    Health Care

    KRISPY KREME® Sweetens Hoops Hysteria with New Bracket Bash Dozen Beginning Thursday, March 19

    Fans can also enjoy a slam dunk deal Thursday through Sunday: $2 Original Glazed® dozen with purchase of any dozen With bracket season tipping off, Krispy Kreme's® new Bracket Bash Dozen is a buzzer-beater sure to win with your squad. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260318992719/en/Fans can also enjoy a slam dunk deal Thursday through Sunday: $2 Original Glazed® dozen with purchase of any dozen Beginning Thursday, March 19 through Sunday, March 22, Krispy Kreme's Bracket Bash Dozen will sweeten hoops hysteria for fans hosting parties with friends and family or going head-to-head with colleagues for bragging righ

    3/18/26 6:00:00 AM ET
    $DNUT
    Food Chains
    Consumer Staples

    $ADAG
    $ADBE
    $AGFY
    $AGYS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Agrify Corporation

    SC 13D/A - Agrify Corp (0001800637) (Subject)

    11/29/24 4:30:03 PM ET
    $AGFY
    Farming/Seeds/Milling
    Consumer Staples

    Amendment: SEC Form SC 13D/A filed by Agrify Corporation

    SC 13D/A - Agrify Corp (0001800637) (Subject)

    11/29/24 4:30:03 PM ET
    $AGFY
    Farming/Seeds/Milling
    Consumer Staples

    Amendment: SEC Form SC 13D/A filed by Minim Inc.

    SC 13D/A - MINIM, INC. (0001467761) (Subject)

    11/15/24 5:00:07 PM ET
    $MINM
    Telecommunications Equipment
    Utilities